At a glance
- Originator Bristol-Myers Squibb
- Class Antipsychotics
- Mechanism of Action Opioid receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psychotic disorders
Most Recent Events
- 06 Oct 1998 No-Development-Reported for Psychotic disorders in USA (unspecified route)
- 01 Mar 1996 Preclinical development for Psychotic disorders in USA (unspecified route)